Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Research for Patient Benefit programme- West Midlands Competition 48 Stage 1 Competition 47 Stage 2 Minutes

Contents

Published: 24 November 2022

Version: 1.0 November 2022

Print this document

Minutes for the Research for Patient Benefit (RfPB) programme West Midlands Regional Advisory Committee meeting to discuss Stage 2 applications to Competition 47 and Stage 1 applications to Competition 48.

Date and Location

Tuesday 20 September 2022 Virtual Meeting

In attendance

Committee members

Dr Rebecca Kearney (Chair)
Dr Opeyemi Babatunde
Professor Matthew Brookes
Professor Julie Bruce
Dr Claire Burton
Dr Keith Couper
Mrs Caroline Dean
Professor Thomas Dietrich
Mr Adrian Gardner
Dr Francis Gilchrist
Ms Louise Rowan
Dr Jason Schaub
Dr Simon White

Secretariat

Dr Scott Thomson (NIHR)
Dr Ianina Conte (NIHR)
Ms Sadika Aktar (NIHR)
Ms Gemma Paine (NIHR)
Professor Marian Knight (Programme Director)

Observers

Dr Chris Gale (LDN Chair)
Ms Nikki Totton (RDS YH)
Ms Mary Feeney (RDS LDN)
Dr Dean Phillips (RDS SC)
Dr Helen Close (RDS NE)

Competition 47 Stage 2 applications considered

NIHR204360: Exploring the experience of children who have provided cardiopulmonary resuscitation (CPR) and the impact of CPR training
Conflicts: Dr Rebecca Kearney, Dr Keith Couper, Professor Julie Bruce left the room
Final outcome: Conditional support

NIHR204332: Mental health prevention and promotion in a general practice setting: A feasibility study.
Conflicts: None
Final outcome: Conditional support

NIHR204354: Menopause GAP: exploring inequalities in menopause care in GenerAl Practice using qualitative methodology
Conflicts: Dr Rebecca Kearney, Dr Keith Couper, Professor Julie Bruce left the room
Final outcome: Conditional support

Competition 48 Stage 1 applications considered

NIHR204901: Quantifying disparities in HRT prescribing in the UK. An analysis of routinely-collected healthcare data
Conflicts: Dr Keith Couper remained out of the room, Professor Matthew Brookes left the room
Outcome: Invite to Stage 2
The Committee made the following comments:

NIHR204926: Reducing Severe Asthma Attacks by using Prescription Alerts for Excessive Use of Reliever Inhalers to Target High Risk Children: A Randomised Controlled Trial
Conflicts: Dr Dean Phillips (Observer)
Outcome: Invite to Stage 2

NIHR204971: The Mrs TEA Study: Multi-centre feasibility Randomised controlled trial of a person-centred Smartwatch Technology-Enabled, physical Activity programme for intensive care survivors from under-served groups.
Conflicts: None
Outcome: Rejected

NIHR204920: A feasibility study of anti-reflux surgery for the prevention of disease progression and symptom control in Idiopathic Pulmonary Fibrosis
Conflicts: Professor Matthew Brookes
Outcome: Rejected

NIHR204942: Adaptation and validation of a patient-reported outcome measure capturing Long COVID symptom burden in adolescents: The Symptom Burden Questionnaire for Long COVID in Young People (SBQ-LC-YP)
Conflicts: Professor Matthew Brookes remained out of the room
Outcome: Invite to Stage 2

NIHR204964: Mobile Health Biometrics to Enhance Exercise and Physical Activity Adherence in Type 1 Diabetes (MOTIVATE-T1D)
Conflicts: Professor Matthew Brookes remained out of the room
Outcome: Rejected

NIHR204932: Increasing the uptake of annual health checks in children and young people with moderate-profound learning disability: A development and feasibility study
Conflicts: Professor Matthew Brookes remained out of the room. Professor Julie Bruce, Dr Keith Couper, and Dr Rebecca Kearney left the room
Outcome: Rejected

NIHR204938: Improving patients, carers, and primary care healthcare professionals’ experiences of discharge communication from specialist palliative care to community settings: a qualitative interview study
Conflicts: Dr Keith Couper left the room, Professor Matthew Brookes remained out of the room
Outcome: Invite to Stage 2

NIHR204888: Skin Hygiene and Emollients in Later Life: Co-production of tailored interventions to support best skin care practice for older care home residents (SHELL–Co-production).
Conflicts: Dr Opeyemi Babatunde left the room
Outcome: Rejected

NIHR204965: COmparison of Symptom scores in patients undergoing Trans vaginal and trans Anal Rectocele Surgery (CO-STARS)
Conflicts: Mr Adrian Gardner, Professor Matthew Brookes, Professor Julie Bruce left the room
Outcome: Rejected

NIHR204992: Understanding and optimising hospital outpatient services for people living with dementia: an ethnographic and intervention development study
Conflicts: None
Outcome: Invite to Stage 2

NIHR204918: Ethical decisions and Management of withholding/withdrawing life-sustaining treatments in adult ICUs: A qualitative study of Bereaved Relatives’ perspectives And Care Experiences (EMBRACE)
Conflicts: None
Outcome: Rejected

NIHR204927: Influenza, MenACWY, HPV and COVID-19 vaccines in children: uptake, safety and effectiveness during the COVID-19 pandemic in the UK.
Conflicts: None
Outcome: Invite to Stage 2

NIHR205003: Understanding the impacts of Attention Deficit Hyperactivity Disorder (ADHD) on mothers during the perinatal period
Conflicts: Professor Matthew Brookes left the room
Outcome: Rejected

NIHR204948: Therapeutic puppetry for people living with dementia: developing and evaluating a care worker training intervention.
Conflicts: None
Outcome: Rejected

Outcomes Table

The tables below display the mean score for each application that was assessed in the regional assessment committee meeting, and excludes applications which were rejected during the scrutiny and triage processes. The number of applications receiving each mean score are listed. The RfPB fundable range is 6-10, although a score of 6-10 does not guarantee funding or an invitation to Stage 2. In exceptional circumstances and with approval from the Programme Director, applications may be invited/funded which fall below the fundable range.

In exceptional circumstances, applications which fall below the fundable range may be invited to Stage 2 or recommended for funding by the Committee. The Programme Director reviews in detail any applications recommended for funding with a score below 7.

Stage 2

ScoreRangeNumber of applications
9.0 - 10.0 Fundable 0
8.0 - 8.9 Fundable
7.0 - 7.9 Fundable
6.0 - 6.9 Fundable
5.0 - 5.9 Rejected
4.0 - 4.9 Rejected
3.0 - 3.9 Rejected
2.0 - 2.9 Rejected
1.0 - 1.9 Rejected

Stage 1 

ScoreRangeNumber of applications
9.0 - 10.0 Invited 0
8.0 - 8.9 Invited
7.0 - 7.9 Invited
6.0 - 6.9 Invited
5.0 - 5.9 Rejected
4.0 - 4.9 Rejected
3.0 - 3.9 Rejected
2.0 - 2.9 Rejected
1.0 - 1.9 Rejected